English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Sep 16, 2018

ASTRAZENECA: US FDA approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukemia

Press release submission | Sep 5, 2018

LIVONGO HEALTH: Becomes First Comprehensive Diabetes Offering to Add Abbott’s FreeStyle® Libre Pro System to Platform

Press release submission | Sep 5, 2018

NUVASIVE INC: To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

Press release submission | Aug 29, 2018

CETERIX ORTHOPAEDICS: Announces FDA Clearance of New Suture Cartridge, Providing Increased Flexibility and Enhanced Options for Surgeons

Press release submission | Aug 29, 2018

ATRICURE, INC.: Announces Completion of Patient Enrollment in the CONVERGE IDE Clinical Trial

Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries

Marian Johns | Aug 28, 2018

UCLA study shows curcumin supplement may improve mood, memory

Marian Johns | Aug 28, 2018

Engineered flu virus may lead to at-home nasal vaccine

Trending

Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'

+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects

Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment

+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'

  • « First
  • «
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily